CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 46 enrolled
Drug / intervention
POD FTdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04940793
NCT04940793N/ACompleted
CompareCT.gov

Visual and Refractive Outcomes of a New Diffractive Trifocal Toric Intraocular Lens

Beaver-Visitec International, Inc.·observational·Posted Jun 28, 2021·Updated Jun 28, 2021

In Brief

An observational study evaluating POD FT for Cataract. Completed, enrolled 46 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate the visual performance and refractive predictability with the diffractive toric Finevision POD FT IOL. Predicted and achieved visual outcomes, visual performance at near, intermediate and far distance as well as photic phenomena, rotational stability and spectacle independence will be investigated. The follow-up period is 3 months after which vision and refraction should have stabilized.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesPortugal
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 28, 2021
Enrollment StartJul 18, 2017
Primary CompletionJan 23, 2019
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 5.0 years ago

Interventions

POD FTdevice

Cataract surgery